Table 2 Analysis of factors associated with quality of life
From: Post treatment quality of life among Sri Lankan women with breast cancer
Variables | Age | Type of surgery | Axillary surgery | ||||
|---|---|---|---|---|---|---|---|
≤60 years | > 60 years | BCS | Mastectomy | Sentinel lymph node biopsy | Axillary lymph node dissection | ||
EORTC QLQ-C30* score | |||||||
Global health status | Median | 83.3 | 58.3 | 83.3 | 66.7 | 70.8 | 75 |
Range | 8.3–100 | 25–100 | 25–100 | 8.33–100 | 8.33–100 | 25–100 | |
p | 0.135 | 0.414 | 0.550 | ||||
Physical function | Median | 73.33 | 73.33 | 73.33 | 73.33 | 66.67 | 80 |
Range | 33.3–100 | 41.7–100 | 33.3–100 | 33.3–100 | 33.3–100 | 33.3–100 | |
p | 0.531 | 0.962 | 0.181 | ||||
Role function | Median | 83.3 | 83.3 | 83.3 | 83.3 | 91.7 | 83.3 |
Range | 0–100 | 16.7–100 | 16.7–100 | 0–100 | 66.7–100 | 16.7–100 | |
p | 0.087 | 0.429 | 0.78 | ||||
Emotional function | Median | 91.7 | 75 | 91.7 | 75 | 91.7 | 91.7 |
Range | 0–100 | 16.7–100 | 0–100 | 0–100 | 16.7–100 | 16.7–100 | |
p | 0.587 | 0.745 | 0.759 | ||||
Cognitive function | Median | 83.3 | 83.3 | 83.3 | 83.3 | 83.3 | 83.3 |
Range | 33.3–100 | 50–100 | 50–100 | 33.3–100 | 33.3–100 | 50–100 | |
p | 0.108 | 0.309 | 0.501 | ||||
Social function | Median | 100 | 100 | 100 | 100 | 100 | 100 |
Range | 16.7–100 | 0–100 | 0–100 | 16.7–100 | 50–100 | 0–100 | |
p | 0.27 | 0.193 | 0.81 | ||||
BR 23 Score** | |||||||
Body image | Median | 86.11 | 83.33 | 100 | 83.33 | 95.83 | 83.33 |
Range | 16.7–100 | 16.7–100 | 16.7–100 | 41.7–100 | 16.7–100 | 16.7–100 | |
p | 0.874 | 0.375 | 0.645 | ||||
Sexual functioning | Median | 16.7 | 0 | 16.7 | 8.3 | 16.7 | 0 |
Range | 0–100 | 0–33.3 | 0–100 | 0–100 | 0–100 | 0–100 | |
p | 0.145 | 0.172 | 0.236 | ||||
Sexual enjoyment | Median | 33.3 | 16.7 | 33.3 | 33.3 | 33.3 | 33.3 |
Range | 0–100 | 0–66.7 | 0–100 | 0–100 | 0–100 | 0–100 | |
p | 0.57 | 0.283 | 0.393 | ||||
Future perspective | Median | 100 | 66.7 | 100 | 100 | 83.3 | 100 |
Range | 0–100 | 0–100 | 0–100 | 0–100 | 0–100 | 0–100 | |
p | 0.227 | 0.949 | 0.595 | ||||
Systemic therapy | Median | 23.8 | 28.5 | 28.5 | 23.8 | 35.7 | 19.1 |
Range | 0–90.4 | 0–90.4 | 0–85.7 | 0–90.4 | 9.5–90.4 | 0–90.5 | |
p | 0.636 | 0.811 | 0.009 | ||||
Breast symptoms | Median | 16.7 | 16.7 | 16.7 | 16.7 | 16.7 | 16.7 |
Range | 0–66.7 | 0–66.7 | 0–66.7 | 0–33.3 | 0–66.7 | 0–66.7 | |
p | 0.27 | 0.469 | 0.393 | ||||
Arm symptoms | Median | 22.2 | 22.2 | 11.1 | 22.2 | 22.2 | 22.2 |
Range | 0–77.8 | 0–66.7 | 0–55.6 | 0–77.8 | 0–66.7 | 0–77.8 | |
p | 0.689 | 0.185 | 0.84 | ||||
Hair loss | Median | 0 | 33.3 | 16.7 | 0 | 66.7 | 0 |
Range | 0–100 | 0–100 | 0–100 | 0–100 | 0–100 | 0–100 | |
p | 0.084 | 0.859 | 0.009 | ||||